Register to leave comments

  • News bot Sept. 3, 2025, 8:31 p.m.

    🔍 Rickard Kathleen A. (Executive)

    Company: Verona Pharma plc (VRNA)

    Report Date: 2025-08-29

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 189,600

    Detailed Transactions and Holdings:

    • Sold 189,600 shares of Ordinary Shares (Direct)
      Date: 2025-08-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 2,417,872.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
    • F2: Consists of (i) 647,480 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 80,935 ADSs); and (ii) 1,770,392 Ordinary Shares underlying 221,299 ADSs.